Yan Tereshko
Overview
Explore the profile of Yan Tereshko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dal Bello S, Ceccarelli L, Tereshko Y, Gigli G, DAnna L, Valente M, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077787
The association between malnutrition and poor outcomes in stroke patients has, to date, been evaluated using composite scores derived from laboratory measurements. However, Bioelectrical Impedance Analysis (BIA) and its advanced...
2.
Tereshko Y, Dal Bello S, Lettieri C, Belgrado E, Gigli G, Merlino G, et al.
Toxins (Basel)
. 2024 Nov;
16(11).
PMID: 39591255
Trigeminal neuralgia is a neuropathic pain syndrome responsive to botulinum toxin type A therapy. This review had the goal of analyzing the different studies published from 2002 to January 2024...
3.
Tereshko Y, Dal Bello S, Belgrado E, Di Lorenzo C, Pittino A, Filippi F, et al.
Neurol Int
. 2024 Nov;
16(6):1203-1213.
PMID: 39585050
Aims: The aim of this study is to assess the sleep quality and daytime sleepiness improvement in chronic migraineurs after 6 months of a 2:1 KD (ketogenic diet) and LGID...
4.
Mare A, Cella A, Tereshko Y, Toraldo F, Gigli G, Valente M, et al.
Expert Opin Drug Metab Toxicol
. 2024 Aug;
20(9):873-880.
PMID: 39215446
Introduction: Antiplatelets and oral anticoagulants are commonly used to treat patients with various cardiovascular and cerebrovascular diseases. However, the primary concern for clinicians remains the risk of bleeding, thus necessitating...
5.
Burini A, Pellitteri G, Merlino G, Nilo A, Tereshko Y, Dolso P, et al.
Expert Rev Neurother
. 2024 Jul;
24(10):997-1009.
PMID: 39082506
Introduction: Restless legs syndrome (RLS) is a sensory-motor sleep disorder that affects up to 13% of adults in the Western world and 2-4% of children. It impairs night sleep with...
6.
Merlino G, Romoli M, Ornello R, Foschi M, Del Regno C, Toraldo F, et al.
Eur Stroke J
. 2024 Apr;
9(3):613-622.
PMID: 38624043
Introduction: Mechanical thrombectomy (MT) is the standard treatment for acute ischemic stroke (AIS) due to anterior large vessel occlusion (LVO). Despite successful recanalization, some patients remain disabled after 3 months....
7.
Tereshko Y, Belgrado E, Lettieri C, Dal Bello S, Merlino G, Gigli G, et al.
Neurol Int
. 2024 Mar;
16(2):349-355.
PMID: 38525705
Auriculotemporal neuralgia is a rare facial pain disorder with no therapeutic evidence for refractory cases. We described a male patient with right auriculotemporal neuralgia, refractory to anesthetic nerve blocks and...
8.
Dal Bello S, Lorenzut S, Saccomano E, Tereshko Y, Gigli G, Pucillo C, et al.
Pharmaceuticals (Basel)
. 2024 Feb;
17(2).
PMID: 38399365
Background: Recently, research on the pathogenesis of multiple sclerosis (MS) has focused on the role of B lymphocytes and the possibility of using specific drugs, such as Ocrelizumab and Rituximab,...
9.
Negro I, Pez S, Versace S, Marziali A, Gigli G, Tereshko Y, et al.
Medicina (Kaunas)
. 2024 Jan;
60(1).
PMID: 38276041
Multiple sclerosis is a chronic, autoimmune-mediated, demyelinating disease whose pathogenesis remains to be defined. In past years, in consideration of a constantly growing number of patients diagnosed with multiple sclerosis,...
10.
Mare A, Lorenzut S, Janes F, Gentile C, Marinig R, Tereshko Y, et al.
Expert Opin Drug Metab Toxicol
. 2024 Jan;
20(1-2):25-36.
PMID: 38275111
Introduction: The drug most frequently used for thrombolysis in cases of acute ischemic stroke (AIS) is alteplase. However, there is moderate-to-high-quality evidence that tenecteplase has similar or higher efficacy and...